histamine has been researched along with Colitis, Granulomatous in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of histamine-2 receptor antagonists (H2RAs) use causing inflammatory bowel diseases (IBD) has been reported in few isolated observational studies; however, pooled estimation of IBD risk has not been done." | 9.22 | Use of histamine-2 receptor antagonists and risk of inflammatory bowel diseases: A systematic review and meta-analysis of observational studies. ( Chandran, VP; D'sa, FF; Fernandes, EZ; Kesarkar, SV; Kunhikatta, V; Nair, S; Rashid, M; Swaminathan, L; Thunga, G, 2022) |
| "The effect of histamine-2 receptor antagonists (H2RAs) use causing inflammatory bowel diseases (IBD) has been reported in few isolated observational studies; however, pooled estimation of IBD risk has not been done." | 5.22 | Use of histamine-2 receptor antagonists and risk of inflammatory bowel diseases: A systematic review and meta-analysis of observational studies. ( Chandran, VP; D'sa, FF; Fernandes, EZ; Kesarkar, SV; Kunhikatta, V; Nair, S; Rashid, M; Swaminathan, L; Thunga, G, 2022) |
| " Therefore, tissue particles from normal subjects and from patients suffering from different diseases (Crohn's disease, ulcerative colitis, intestinal polyps) obtained at routine coloscopy were exposed to either Hanks or anti-IgE solution to determine the spontaneous or the anti-IgE-induced histamine release, expressed as the percentage of the total histamine content of the biopsy." | 3.67 | Histamine release from human colonic mucosa in response to anti-IgE. ( Baenkler, HW; Hörauf, AM; Matek, M; Raithel, M, 1989) |
| "Crohn disease is considered a consequence of inappropriate upregulation of immune reactions evoked by the intestinal microflora or luminal antigens." | 2.70 | Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease. ( Brünner, N; Holten-Andersen, M; Mortensen, T; Nielsen, HJ; Rask-Madsen, J; Sørensen, S, 2001) |
| "In the allergic bronchial asthma model using HDC-KO mice it was found that histamine positively controls eosinophilia, but not bronchial hypersensitivity." | 2.46 | Histamine synthesis and lessons learned from histidine decarboxylase deficient mice. ( Ohtsu, H, 2010) |
| "Histamine is a key immunoregulatory mediator in immediate-type hypersensitivity reactions and chronic inflammatory responses, in particular histamine suppresses proinflammatory responses to bacterial ligands, through histamine receptor 2 (H2R)." | 1.43 | Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease. ( Akdis, CA; Ferstl, R; Frei, R; Groeger, D; Jutel, M; Konieczna, P; OʼMahony, L; Perez, NR; Schiavi, E; Smolinska, S, 2016) |
| "Histamine pretreatment of non-IBD control tissues reduced anti-IgE responses to levels seen in IBD colon but had no effect in small intestine." | 1.30 | Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. ( Crowe, SE; Luthra, GK; Perdue, MH, 1997) |
| "Histamine responses were blocked by the H1 antagonist mepyramine but were not altered by a diamine oxidase inhibitor." | 1.29 | Altered small intestinal smooth muscle function in Crohn's disease. ( Collins, SM; Huizinga, JD; Riddell, RH; Vermillion, DL, 1993) |
| "than in those with Crohn's disease and a control group." | 1.26 | Skin reactivity and phagocytic function of neutrophil leucocytes in Crohn's disease and ulcerative colitis. ( Juhlin, L; Krause, U; Michaëlsson, G, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (30.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'sa, FF | 1 |
| Fernandes, EZ | 1 |
| Kesarkar, SV | 1 |
| Swaminathan, L | 1 |
| Kunhikatta, V | 1 |
| Rashid, M | 1 |
| Thunga, G | 1 |
| Chandran, VP | 1 |
| Nair, S | 1 |
| Sbeih, N | 1 |
| Bourguiba, R | 1 |
| Hoyeau-Idrissi, N | 1 |
| Launay, JM | 1 |
| Callebert, J | 1 |
| Canioni, D | 1 |
| Sokol, H | 1 |
| Hentgen, V | 1 |
| Grateau, G | 1 |
| Hermine, O | 1 |
| Georgin-Lavialle, S | 1 |
| Hagel, AF | 1 |
| de Rossi, T | 1 |
| Konturek, PC | 1 |
| Albrecht, H | 1 |
| Walker, S | 1 |
| Hahn, EG | 3 |
| Raithel, M | 4 |
| Smolinska, S | 1 |
| Groeger, D | 1 |
| Perez, NR | 1 |
| Schiavi, E | 1 |
| Ferstl, R | 1 |
| Frei, R | 1 |
| Konieczna, P | 1 |
| Akdis, CA | 1 |
| Jutel, M | 1 |
| OʼMahony, L | 1 |
| Nägel, A | 1 |
| Zopf, Y | 1 |
| deRossi, T | 1 |
| Stengel, Ch | 1 |
| Hagel, A | 1 |
| Kressel, J | 1 |
| Konturek, P | 1 |
| Ohtsu, H | 1 |
| TALLARIGO, A | 1 |
| CACUDI, G | 1 |
| Fogel, W | 1 |
| Lewiński, A | 1 |
| Jochem, J | 1 |
| Doldi, K | 1 |
| Manger, B | 1 |
| Koch, B | 1 |
| Riemann, J | 1 |
| Hermanek, P | 1 |
| Kalden, JR | 1 |
| Matek, M | 2 |
| Baenkler, HW | 3 |
| Jorde, W | 1 |
| Wantke, F | 1 |
| Götz, M | 1 |
| Jarisch, R | 1 |
| Araki, Y | 1 |
| Kakegawa, T | 1 |
| Stadil, F | 1 |
| Vermillion, DL | 1 |
| Huizinga, JD | 1 |
| Riddell, RH | 1 |
| Collins, SM | 1 |
| Crowe, SE | 1 |
| Luthra, GK | 1 |
| Perdue, MH | 1 |
| Nielsen, HJ | 1 |
| Mortensen, T | 1 |
| Holten-Andersen, M | 1 |
| Brünner, N | 1 |
| Sørensen, S | 1 |
| Rask-Madsen, J | 1 |
| Kuiarov, AV | 1 |
| Vorob'ev, AA | 1 |
| Nesvizhskiĭ, IuV | 1 |
| Krause, U | 1 |
| Michaëlsson, G | 1 |
| Juhlin, L | 1 |
| Hörauf, AM | 1 |
| Lux, G | 1 |
| Günthner, R | 1 |
| Kohlhäufl, M | 1 |
| Matek, W | 1 |
| Novis, BH | 1 |
| Bank, S | 1 |
| Marks, IN | 1 |
4 reviews available for histamine and Colitis, Granulomatous
| Article | Year |
|---|---|
Use of histamine-2 receptor antagonists and risk of inflammatory bowel diseases: A systematic review and meta-analysis of observational studies.
Topics: Adult; Child; Colitis, Ulcerative; Crohn Disease; Histamine; Histamine H2 Antagonists; Humans; Infla | 2022 |
Histamine synthesis and lessons learned from histidine decarboxylase deficient mice.
Topics: Anaphylaxis; Animals; Asthma; Atherosclerosis; Crohn Disease; Epigenesis, Genetic; Gene Expression R | 2010 |
Histamine in idiopathic inflammatory bowel diseases--not a standby player.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cimetidine; Crohn Disease; Histamine; Histamine An | 2005 |
[Possibility of participation of bacterial factor in the correction of histamine metabolism in the body].
Topics: Adult; Amine Oxidase (Copper-Containing); Animals; Antigens, Bacterial; Bacteria; Basophils; Birds; | 2000 |
2 trials available for histamine and Colitis, Granulomatous
| Article | Year |
|---|---|
Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD).
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Diseas | 2010 |
Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease.
Topics: Adult; Aged; Antibodies, Bacterial; C-Reactive Protein; Clostridium tetani; Crohn Disease; Enzyme-Li | 2001 |
14 other studies available for histamine and Colitis, Granulomatous
| Article | Year |
|---|---|
Histamine elevation in familial Mediterranean fever: A study from the Juvenile Inflammatory Rheumatism cohort.
Topics: Adult; Colchicine; Crohn Disease; Familial Mediterranean Fever; Histamine; Humans; Mast Cells; Masto | 2023 |
Plasma histamine and tumour necrosis factor-alpha levels in Crohn's disease and ulcerative colitis at various stages of disease.
Topics: Adult; Aged; Colitis, Ulcerative; Crohn Disease; Disease Progression; Female; Histamine; Humans; Int | 2015 |
Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
Topics: Adult; Animals; Case-Control Studies; Cells, Cultured; Colitis, Ulcerative; Crohn Disease; Cytokines | 2016 |
[Histamine & lymphatic stasis in the pathogenesis of experimental regional enteritis].
Topics: Crohn Disease; Histamine; Histamine Agents; Ileitis; Lymphatic Vessels | 1958 |
Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.
Topics: Adenocarcinoma; Adult; Antigens, Surface; Cells, Cultured; Cimetidine; Colonic Neoplasms; Crohn Dise | 1984 |
Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy.
Topics: Biopsy; Colitis, Ulcerative; Crohn Disease; Female; Histamine; Histamine Release; Humans; Hypersensi | 1995 |
Dietary treatment of Crohn's disease.
Topics: Amine Oxidase (Copper-Containing); Crohn Disease; Histamine; Humans | 1994 |
Mast cells and histamine release in Crohn's disease.
Topics: Antibodies, Anti-Idiotypic; Crohn Disease; Histamine; Humans; Mast Cells | 1993 |
Altered small intestinal smooth muscle function in Crohn's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbachol; Crohn Disease; Dose-Response Relationship, Dr | 1993 |
Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease.
Topics: Animals; Antibodies, Anti-Idiotypic; Colforsin; Colitis, Ulcerative; Crohn Disease; Histamine; Hista | 1997 |
Skin reactivity and phagocytic function of neutrophil leucocytes in Crohn's disease and ulcerative colitis.
Topics: Adolescent; Adult; Aged; Antigens, Bacterial; Bradykinin; Colitis, Ulcerative; Crohn Disease; Female | 1978 |
Histamine release from human colonic mucosa in response to anti-IgE.
Topics: Antibodies, Anti-Idiotypic; Colitis, Ulcerative; Colon; Crohn Disease; Histamine; Histamine Release; | 1989 |
Biopsy histamine in ulcerative colitis and Crohn's disease.
Topics: Adult; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Female; Histamine; Humans; Intestinal Muco | 1987 |
Gastric acid secretion and intestinal malabsorption.
Topics: Adolescent; Adult; Blind Loop Syndrome; Celiac Disease; Child; Crohn Disease; Duodenal Ulcer; Female | 1973 |